Advertisement Nastech's Q4 revenues up - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Nastech’s Q4 revenues up

Nastech Pharmaceuticals has reported that revenue for the three months ended December 31, 2007 was $6.4 million, compared to $4.8 million for the quarter ended December 31, 2006.

Revenue for the year ended December 31, 2007 was $18.1 million, compared to $28.5 million for the year ended December 31, 2006. Net loss for the three months ended December 31, 2007 was $12 million or $0.47 per share, as compared to a net loss of $10.7 million, or $0.50 per share for the same period of 2006.

The net loss for the year ended December 31, 2007 was $52.4 million or $2.10 per share, as compared to $26.9 million, or $1.27 per share, for the corresponding period of 2006.